Purchase Order 75N92B26P00005
Award Date 12/23/25
Potential Completion Date 12/22/26
Potential Value $25K
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95131, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, was awarded a $22,107.60 firm fixed-price purchase order by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) on December 23, 2025, with an ultimate completion date of December 22, 2026. The contract was awarded without a set-aside designation and will be performed in San Jose, California. As a global medical technology manufacturer specializing in flow cytometry systems,...
- Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, was awarded a purchase order valued at $24,924.63 by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD), a component of the National Institutes of Health. The contract, awarded on December 30, 2025, covers a period of performance from December 29, 2025, through July 16, 2026, with an ultimate completion date of July 17, 2026. The award encompasses service contracts for...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, received a contract award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) for $8,217.50. This Blanket Purchase Agreement (BPA) call was awarded on December 18, 2015, with a completion date of December 31, 2015, utilizing firm fixed-price pricing. The contract involved no small business set-aside designation and was performed in Bethesda, Maryland. As a child entity...
- Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, received a $22,500 firm fixed-price contract award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) on December 19, 2019. This contract call was issued under a Blanket Purchase Agreement (BPA) with an ultimate completion date of December 31, 2019, and was awarded without a small business set-aside designation. The work is to be performed in Bethesda, Maryland, where...
- Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, was awarded a Blanket Purchase Agreement (BPA) call contract valued at $14,942.85 by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD), a component of the National Institutes of Health. The contract, awarded on August 24, 2012, with an ultimate completion date of March 31, 2013, was issued on a firm fixed-price basis without a small business set-aside designation....
- Becton, Dickinson and Company, through its BD Biosciences division, was awarded a delivery order contract valued at approximately $12k by the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland, with an award date of October 1, 2006, and completion scheduled for September 30, 2007. This contract utilizes a child vendor entity (UEI: MM5ZHL8SRFY5) under the parent company Becton, Dickinson and Co (UEI: JJFKLGY7TBJ5) and was awarded on a full and open competition basis without...
- Becton, Dickinson and Company (BD Biosciences), a division of BD focused on biomedical research and clinical applications, was awarded a firm fixed price purchase order by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases. The potential value of this contract is $21,578.76. No set-aside designation was used for this award. Performance will take place in San Jose, California, with a completion date of June 14, 2024. This purchase order was...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, received a $5,258.95 firm fixed price Blanket Purchase Agreement (BPA) call award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases on June 14, 2018, with an ultimate completion date of July 31, 2018. The contract was awarded without a set-aside designation and will be performed in Bethesda, Maryland. As a global medical technology manufacturer specializing in flow cytometry...
- Becton, Dickinson and Company, through its BD Biosciences division, was awarded a $22,613.40 firm fixed-price contract call under a Blanket Purchase Agreement by the National Institute of Arthritis and Musculoskeletal and Skin Diseases for the provision of scientific instruments and related services. The contract, awarded on March 11, 2020, with an ultimate completion date of August 31, 2020, will support the institute's research operations at its Bethesda, Maryland facility. No small business...
- Becton, Dickinson and Company (BD), through its BD Biosciences division, has been awarded an 11-month firm fixed price purchase order valued at $200,435.84 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract is for various equipment and laser services to be performed at the agency's facility in Bethesda, Maryland. No set-aside designation was applied to this solicitation. As the prime contractor, BD will leverage its expertise providing...